SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-054808
Filing Date
2021-02-24
Accepted
2021-02-24 16:59:07
Documents
14
Period of Report
2021-02-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d104344d8k.htm   iXBRL 8-K 34616
2 EX-99.1 d104344dex991.htm EX-99.1 22131
6 GRAPHIC g104344page001.jpg GRAPHIC 3576
  Complete submission text file 0001193125-21-054808.txt   193292

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nk-20210224.xsd EX-101.SCH 3066
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nk-20210224_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nk-20210224_pre.xml EX-101.PRE 10952
7 EXTRACTED XBRL INSTANCE DOCUMENT d104344d8k_htm.xml XML 3227
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (858) 633-0300
NantKwest, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 21674481
SIC: 2836 Biological Products, (No Diagnostic Substances)